Published • loading... • Updated
Misinformation, hesitancy could blunt impact of new cancer vaccines
Researchers say misinformation and vaccine skepticism could slow adoption of personalized mRNA cancer shots despite promising trial results and strong immune responses.
- New mRNA cancer vaccines offer significant hope for patients, yet medical experts warn that rising vaccine hesitancy and misinformation could severely blunt their adoption.
- Researchers cite the HPV vaccine as a cautionary tale, noting that decades of misinformation have caused vaccination rates for teenagers to stagnate for four years.
- Lawmakers in 34 states introduced 209 bills this year to limit vaccine access or sow safety doubts, while Idaho Republicans proposed a two-year moratorium on mRNA immunizations.
- Questioning vaccine safety, Republican President Donald Trump and Human Services Secretary Robert Kennedy have amplified skepticism and proposed cutting funding for vaccine research.
- Cancer survivor Chase Johnson, now 37, credits vaccination for peace of mind, though experts emphasize that restoring trust in public health remains critical for new treatments.
Insights by Ground AI
21 Articles
21 Articles
New Cancer Vaccines Are on the Horizon. Disinformation Could Blunt Their Impact.
Nearly five years ago, Chase Johnson was cured of breast cancer — but not of the profound anxiety that it would return. When Johnson was originally diagnosed in 2021, the resident of Cary, North Carolina, was only 31 — nearly a decade away from the age at which regular mammograms are recommended — and she had no history of breast cancer in her family. She only got screened because her dog… Source
·Sacramento, United States
Read Full ArticleCoverage Details
Total News Sources21
Leaning Left16Leaning Right0Center4Last UpdatedBias Distribution80% Left
Bias Distribution
- 80% of the sources lean Left
80% Left
L 80%
C 20%
Factuality
To view factuality data please Upgrade to Premium
